Calcitonin gene-related peptides modulate the acute inflammatory response induced by interleukin-1 in the mouse

Eur J Pharmacol. 1994 Nov 3;264(3):407-15. doi: 10.1016/0014-2999(94)00503-6.

Abstract

Interleukin-1 beta (1 and 5 ng) produced an intense migration of neutrophils into a 6-day-old murine air-pouch at 4 h time-point. Endogenous calcitonin gene-related peptide (CGRP) was found to be involved as a mediator of interleukin-1 beta (5 ng)-induced migration, since the CGRP receptor antagonist, CGRP-(8-37), attenuated the cellular response. The polymorphonuclear leukocyte accumulation induced by both doses of interleukin-1 beta was also potentiated by exogenously added CGRP, a response blocked by CGRP-(8-37). Interleukin-1 beta also caused plasma protein extravasation into the pouch as assessed by measuring leakage of 125I-albumin. Whereas plasma protein extravasation was potentiated by CGRP, again an effect abolished by co-administration of CGRP-(8-37), the antagonist had no effect upon the plasma extravasation induced by the cytokine alone. These results suggest that endogenous CGRP is involved in mediating the cellular response but not plasma protein extravasation evoked by interleukin-1 beta and point to CGRP receptor heterogeneity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Blood Proteins / drug effects*
  • Blood Proteins / metabolism
  • Calcitonin / metabolism
  • Calcitonin Gene-Related Peptide / antagonists & inhibitors
  • Calcitonin Gene-Related Peptide / pharmacology*
  • Calcitonin Gene-Related Peptide / physiology*
  • Calcitonin Gene-Related Peptide / therapeutic use
  • Cell Adhesion / drug effects
  • Cell Movement / drug effects
  • Cell Movement / physiology
  • Dose-Response Relationship, Drug
  • Inflammation / chemically induced
  • Inflammation / drug therapy
  • Interleukin-1 / administration & dosage
  • Interleukin-1 / toxicity*
  • Male
  • Mice
  • Neutrophils / cytology
  • Neutrophils / drug effects*
  • Peptide Fragments / pharmacology*
  • Peptide Fragments / therapeutic use
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / toxicity

Substances

  • Blood Proteins
  • Interleukin-1
  • Peptide Fragments
  • Recombinant Proteins
  • calcitonin gene-related peptide (8-37)
  • Calcitonin
  • Calcitonin Gene-Related Peptide